1. Home
  2. NOG vs ADPT Comparison

NOG vs ADPT Comparison

Compare NOG & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Northern Oil and Gas Inc.

NOG

Northern Oil and Gas Inc.

HOLD

Current Price

$21.48

Market Cap

2.6B

Sector

Energy

ML Signal

HOLD

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$17.33

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOG
ADPT
Founded
2006
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.2B
IPO Year
2000
2019

Fundamental Metrics

Financial Performance
Metric
NOG
ADPT
Price
$21.48
$17.33
Analyst Decision
Buy
Strong Buy
Analyst Count
8
9
Target Price
$31.14
$17.78
AVG Volume (30 Days)
2.6M
1.7M
Earning Date
04-28-2026
05-05-2026
Dividend Yield
6.44%
N/A
EPS Growth
N/A
63.89
EPS
N/A
N/A
Revenue
$2,475,723,000.00
$276,976,000.00
Revenue This Year
$14.07
$3.98
Revenue Next Year
$4.24
$22.72
P/E Ratio
N/A
N/A
Revenue Growth
11.23
54.77
52 Week Low
$20.18
$9.96
52 Week High
$32.62
$20.76

Technical Indicators

Market Signals
Indicator
NOG
ADPT
Relative Strength Index (RSI) 39.06 66.43
Support Level $21.41 $14.87
Resistance Level $22.86 $17.52
Average True Range (ATR) 0.72 0.93
MACD -0.01 0.33
Stochastic Oscillator 22.52 81.33

Price Performance

Historical Comparison
NOG
ADPT

About NOG Northern Oil and Gas Inc.

Northern Oil & Gas Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil and natural gas properties. Its principal business is crude oil and natural gas exploration, development, and production. The company's oil and natural gas sales come from three geographic areas in the United States: the Williston Basin (North Dakota and Montana), the Permian Basin (New Mexico and Texas), the Uinta Basin, and the Appalachian Basin (Pennsylvania and Ohio).

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

Share on Social Networks: